Macquarie Group LTD Vincerx Pharma, Inc. Transaction History

Macquarie Group LTD

  • $79.1 Billion
  • Q2 2025

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024
BUY
$1.07 - $8.06 $284 - $2,143
266 New
266 $1,000

Others Institutions Holding VINC

# of Institutions
2
Shares Held
58K
Call Options Held
0
Put Options Held
0
View Full List

About Vincerx Pharma, Inc.

VINC Quotes by TradingView
  • Ticker VINC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 21,189,800
  • Market Cap $212K
  • Description
  • Vincerx Pharma, Inc., a clinical-stage biopharmaceutical company, researches and develops therapies to address unmet medical needs for the treatment of cancer in the United States. Its lead product candidate is VIP152, a cyclin-dependent kinase-9 inhibitor for treating patients with advanced cancer. The company's preclinical stage product candid...
More about VINC
Track This Portfolio

Track Macquarie Group LTD Portfolio

Follow Macquarie Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email